Weak Sales From Lipitor, Norvasc Hurt Viatris' Q1 Earnings, Lowers Annual Forecast [Yahoo! Finance]
Viatris Inc. (VTRS)
Company Research
Source: Yahoo! Finance
The company reported sales of $3.66 billion, missing the consensus of $3.69 billion. Total net sales declined 2% on a reported basis and increased 2% on a divestiture- adjusted operational basis Brand sales fell 5% to $2.31 billion. The company says the performance reflects strong growth in Emerging Markets and Europe and expansion of business activities in JANZ, offset by unfavorable channel dynamics in North America and expected base business erosion resulting from government price regulations in Japan and Australia. Generic sales reached 1.34 billion, up 4%. Viatris says growth is driven by strong new product launch performance in Developed Markets, along with the improved performance of Wixela and solid performance across broader portfolios in Developed and Emerging Markets. “As a result of our underlying fundamentals and the momentum of our business, we believe we are well positioned to meet our 2024 financial guidance, as well as our full-year range of $450 to $550 millio
Show less
Read more
Impact Snapshot
Event Time:
VTRS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VTRS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VTRS alerts
High impacting Viatris Inc. news events
Weekly update
A roundup of the hottest topics
VTRS
News
- Prevent Blindness Launches "It Started With an Eye Exam" Campaign to Encourage, Educate and Empower the Public to Make Vision and Eye Health a Part of Overall Health Care [Yahoo! Finance]Yahoo! Finance
- Viatris Inc. (NASDAQ:VTRS) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Ocuphire Pharma Announces Financial Results for First Quarter 2024 and Provides Corporate Update [Yahoo! Finance]Yahoo! Finance
- Viatris' (VTRS) Q1 Earnings & Sales Lag Estimates, Stock Down [Yahoo! Finance]Yahoo! Finance
- Viatris (VTRS) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates [Yahoo! Finance]Yahoo! Finance
VTRS
Earnings
- 5/9/24 - Miss
VTRS
Sec Filings
- 5/9/24 - Form 10-Q
- 5/9/24 - Form 8-K
- 4/26/24 - Form 10-K/A
- VTRS's page on the SEC website